SG11201901000XA - Compositions and methods of cell attachment - Google Patents

Compositions and methods of cell attachment

Info

Publication number
SG11201901000XA
SG11201901000XA SG11201901000XA SG11201901000XA SG11201901000XA SG 11201901000X A SG11201901000X A SG 11201901000XA SG 11201901000X A SG11201901000X A SG 11201901000XA SG 11201901000X A SG11201901000X A SG 11201901000XA SG 11201901000X A SG11201901000X A SG 11201901000XA
Authority
SG
Singapore
Prior art keywords
international
pct
street
compositions
methods
Prior art date
Application number
SG11201901000XA
Inventor
Daniel Levner
Dongeun Huh
Kyung Jang
Jacob Fraser
S Jordan Kerns
Antonio Varone
Original Assignee
Emulate Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Emulate Inc filed Critical Emulate Inc
Publication of SG11201901000XA publication Critical patent/SG11201901000XA/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • G01N33/5032—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects on intercellular interactions
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M23/00—Constructional details, e.g. recesses, hinges
    • C12M23/02—Form or structure of the vessel
    • C12M23/16—Microfluidic devices; Capillary tubes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2/00—Peptides of undefined number of amino acids; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M23/00—Constructional details, e.g. recesses, hinges
    • C12M23/20—Material Coatings
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M25/00—Means for supporting, enclosing or fixing the microorganisms, e.g. immunocoatings
    • C12M25/02—Membranes; Filters
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0018—Culture media for cell or tissue culture
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0068—General culture methods using substrates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0658—Skeletal muscle cells, e.g. myocytes, myotubes, myoblasts
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/067—Hepatocytes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5014—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing toxicity
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/30—Organic components
    • C12N2500/32—Amino acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2521/00—Culture process characterised by the use of hydrostatic pressure, flow or shear forces
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2533/00—Supports or coatings for cell culture, characterised by material
    • C12N2533/30—Synthetic polymers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2533/00—Supports or coatings for cell culture, characterised by material
    • C12N2533/50—Proteins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2533/00—Supports or coatings for cell culture, characterised by material
    • C12N2533/50—Proteins
    • C12N2533/52—Fibronectin; Laminin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2533/00—Supports or coatings for cell culture, characterised by material
    • C12N2533/50—Proteins
    • C12N2533/54—Collagen; Gelatin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2533/00—Supports or coatings for cell culture, characterised by material
    • C12N2533/90—Substrates of biological origin, e.g. extracellular matrix, decellularised tissue
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2535/00—Supports or coatings for cell culture characterised by topography
    • C12N2535/10—Patterned coating
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2537/00—Supports and/or coatings for cell culture characterised by physical or chemical treatment
    • C12N2537/10—Cross-linking

Abstract

INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (43) International Publication Date 18 January 2018 (18.01.2018) W I PO I PCT ill~~~~~~~~ 011101010VIIIOH olo omm offilm °nom° oimIE (10) International Publication Number WO 2018/013718 Al (51) International Patent Classification: C12M 1/12 (2006.01) G01N 33/50 (2006.01) C12N 5/07 (2010.01) (21) International Application Number: PCT/US2017/041762 (22) International Filing Date: 12 July 2017 (12.07.2017) (25) Filing Language: English (26) Publication Language: English (30) Priority Data: 62/361,259 12 July 2016 (12.07.2016) US (71) Applicant: EMULATE, INC. [US/US]; 27 Drydock, Boston, MA 02210 (US). (72) Inventors: LEVNER, Daniel; 55 Sewall Avenue, 5C, Brookline, MA 02446 (US). HUH, Dongeun, Huh; 3411 Chestnut Street, #433, Philadelphia, PA 19104 (US). JANG, Kyung, Jin; 2 Greenmeadow Lane, Andover, MA 01810 (US). FRASER, Jacob; 19 Kingston Street, Apt. 2, Somerville, MA 02144 (US). KERNS, Jordan; 7 Her- itage Drive, Reading, MA 01867 (US). VARONE, Anto- nio; 4975 Washinton Street, Unit 118, West Roxbury, MA 02132 (US). (74) Agent: CARROLL, Peter, G. et al.; Medlen & Carroll, LLP, 1440 Broadway, Suite 1010, Oakland, CA 94612 (US). (81) Designated States (unless otherwise indicated, for every kind of national protection available): AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JO, JP, KE, KG, KH, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW. (84) Designated States (unless otherwise indicated, for every kind of regional protection available): ARIPO (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW), Eurasian (AM, AZ, BY, KG, KZ, RU, TJ, TM), European (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR), OAPI (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG). Published: with international search report (Art. 21(3)) = (54) Title: COMPOSITIONS AND METHODS OF CELL ATTACHMENT Sulfa-SAN PAH Suifosaccinintidyl e-14 . -aido-2'-riitrophonvlaminathexaaava PAW 492.40 1-1 Spacer Am 18,2 A cc FIGURE 1 N O (57) : Compositions, devices and methods are described for improving adhesion, attachment, and/or differentiation of cells in cc a microfluidic device or chip. In one embodiment, one or more ECM proteins are covalently coupled to the surface of a microchannel of a microfluidic device. The microfluidic devices can be stored or used immediately for culture and/or support of living cells such as O mammalian cells, and/or for simulating a function of a tissue, e.g., a liver tissue, muscle tissue, etc. Extended adhesion and viability with sustained function over time is observed. C
SG11201901000XA 2016-07-12 2017-07-12 Compositions and methods of cell attachment SG11201901000XA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201662361259P 2016-07-12 2016-07-12
PCT/US2017/041762 WO2018013718A1 (en) 2016-07-12 2017-07-12 Compositions and methods of cell attachment

Publications (1)

Publication Number Publication Date
SG11201901000XA true SG11201901000XA (en) 2019-03-28

Family

ID=59676739

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201901000XA SG11201901000XA (en) 2016-07-12 2017-07-12 Compositions and methods of cell attachment

Country Status (7)

Country Link
US (7) US11733234B2 (en)
EP (1) EP3484991A4 (en)
AU (1) AU2017297408A1 (en)
CA (1) CA3032997A1 (en)
GB (2) GB2558336B (en)
SG (1) SG11201901000XA (en)
WO (1) WO2018013718A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018013718A1 (en) * 2016-07-12 2018-01-18 EMULATE, Inc. Compositions and methods of cell attachment
CA3069742C (en) * 2017-07-12 2021-06-22 EMULATE, Inc. Surface functionalization
US11518971B2 (en) * 2018-11-27 2022-12-06 Research Triangle Institute Method and apparatus for spatial control of cellular growth

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7160687B1 (en) 1997-05-29 2007-01-09 Cellomics, Inc. Miniaturized cell array methods and apparatus for cell-based screening
US7453486B2 (en) 2000-12-13 2008-11-18 Orbotech Ltd Pulse light pattern writer
US7157049B2 (en) * 2001-11-20 2007-01-02 Nagaoka & Co., Ltd. Optical bio-discs and fluidic circuits for analysis of cells and methods relating thereto
EP2495310A3 (en) * 2005-05-24 2013-03-27 The Regents Of the University of California Microscale micropatterned engineered in vitro tissue
JP2010537633A (en) * 2007-08-30 2010-12-09 プレジデント・アンド・フェロウズ・オブ・ハーバード・カレッジ Multi-well culture plate with compliant surface
EP3778858A1 (en) 2008-07-16 2021-02-17 Children's Medical Center Corporation Device with microchannels and method of use
EP2321405A4 (en) * 2008-08-08 2012-09-12 Agency Science Tech & Res Microfluidic continuous flow device
US9040665B2 (en) 2008-09-30 2015-05-26 Case Western Reserve University Controlled cross-linking processing of proteins
FR2937050A1 (en) * 2008-10-10 2010-04-16 Inst Curie CELL CULTURE DEVICE
US20100135855A1 (en) * 2008-11-26 2010-06-03 Koninklijke Philips Electronics N.V. Method for depositing substances on a support
WO2010099310A1 (en) 2009-02-26 2010-09-02 Wake Forest University Health Sciences Endothelial scaffolds
US20120135446A1 (en) * 2009-03-04 2012-05-31 Maine Institute For Human Genetics & Health, Inc Microfluidic Device and Related Methods
WO2013086502A1 (en) 2011-12-09 2013-06-13 President And Fellows Of Harvard College Organ chips and uses thereof
SE538193C2 (en) * 2012-07-05 2016-03-29 Scania Cv Ab SCR system and procedure of an SCR system
WO2014143998A1 (en) * 2013-03-15 2014-09-18 The Broad Institute Systems and methods for culturing epithelial cells
CN105658786B (en) * 2013-08-28 2020-07-03 普罗米迪拉生物科学公司 Method for producing adult liver progenitor cells
CA2929172A1 (en) 2013-10-30 2015-05-07 Jason MIKLAS Devices and methods for three-dimensional tissue culturing using contractile force
EP3574985A1 (en) * 2013-12-20 2019-12-04 President And Fellows Of Harvard College Organomimetic devices and methods of use and manufacturing thereof
JP2017504320A (en) 2013-12-20 2017-02-09 プレジデント アンド フェローズ オブ ハーバード カレッジ Low shear microfluidic device and methods of use and manufacture thereof
WO2015108944A2 (en) * 2014-01-14 2015-07-23 Colorado State University Research Foundation Stem cell-derived hepatocytes in co-culture and uses thereof
WO2016004394A1 (en) 2014-07-03 2016-01-07 Texas Tech University System Microfluidic cardiovascular system and method
WO2016054288A1 (en) * 2014-09-30 2016-04-07 Taylor Lansing D A human liver microphysiology platform and self assembly liver acinus model and methods of their use
GB2556270B (en) * 2015-07-27 2021-05-12 Univ Pennsylvania Lung disease models on a chip
WO2017096192A1 (en) * 2015-12-04 2017-06-08 President And Fellows Of Harvard College Devices for simulating a function of a liver tissue and methods of use and manufacturing thereof
WO2018013718A1 (en) * 2016-07-12 2018-01-18 EMULATE, Inc. Compositions and methods of cell attachment

Also Published As

Publication number Publication date
GB201711206D0 (en) 2017-08-23
US20180024118A1 (en) 2018-01-25
US20180024116A1 (en) 2018-01-25
US11536714B2 (en) 2022-12-27
US11549937B2 (en) 2023-01-10
US20230341378A1 (en) 2023-10-26
US11506653B2 (en) 2022-11-22
US11733234B2 (en) 2023-08-22
GB2584973B (en) 2021-04-14
CA3032997A1 (en) 2018-01-18
AU2017297408A1 (en) 2019-02-21
GB202014449D0 (en) 2020-10-28
EP3484991A1 (en) 2019-05-22
US20180024119A1 (en) 2018-01-25
US20180024120A1 (en) 2018-01-25
EP3484991A4 (en) 2020-03-18
WO2018013718A1 (en) 2018-01-18
US11506652B2 (en) 2022-11-22
GB2558336B (en) 2020-10-28
US11519903B2 (en) 2022-12-06
US20180023050A1 (en) 2018-01-25
GB2558336A (en) 2018-07-11
US20180024117A1 (en) 2018-01-25
GB2584973A (en) 2020-12-23

Similar Documents

Publication Publication Date Title
SG11201804700VA (en) Devices and methods for simulating a function of a liver tissue
SG11201901621VA (en) Development of spinal cord on a microfluidic chip
SG11201806988UA (en) Improved differentiation method
SG11201909501TA (en) Personalized 3d neural culture system for generating human oligodendrocytes and studying myelination in vitro
SG11201809913PA (en) Methods for detecting target nucleic acids in a sample
SG11201810003UA (en) Using programmable dna binding proteins to enhance targeted genome modification
SG11201804710TA (en) Devices for simulating a function of a liver tissue and methods of use and manufacturing thereof
SG11201407702XA (en) Methods and compositions for rna-directed target dna modification and for rna-directed modulation of transcription
SG11201810171SA (en) Kras g12c inhibitors
SG11201910173YA (en) Device and method for microfluidics-based 3d bioprinting
SG11201805451TA (en) Immune effector cell therapies with enhanced efficacy
SG11201908240YA (en) Methods for evaluating tumor cell spheroids using 3d microfluidic cell culture device
SG11201811549UA (en) Boronic acid derivatives and therapeutic uses thereof
SG11201803703UA (en) Anti-complement factor c1q fab fragments and uses thereof
SG11201805420SA (en) Antibodies and conjugates thereof
SG11201810780XA (en) Single use bioreactor
SG11201809614VA (en) Method for the fabrication of three-dimensional objects and apparatus for same
SG11201807538PA (en) Crispr-cpf1-related methods, compositions and components for cancer immunotherapy
SG11201901000XA (en) Compositions and methods of cell attachment
SG11201900057WA (en) Biomatrix scaffolds for use in diagnosing and modeling cancer
SG11201807041PA (en) Improved preparations of adult liver progenitor cells
SG11201808762XA (en) Diagnostic methods for patient specific therapeutic decision making in cancer care
SG11201408405WA (en) Engineered three-dimensional connective tissue constructs and methods of making the same
SG11201900081QA (en) Removing bubbles in a microfluidic device
SG11201900058YA (en) Method of generating mesenchymal stem cells and uses thereof